US Capital Global Launches Global M&A Division for the Emerging Growth and Middle Market Arena

Written by Customer Service on May 5, 2023. Posted in Mergers And Acquisitions.

US Capital Global builds a team of seasoned investment professionals to provide sell-side, buy-side, and divestiture financing and advisory for M&A, serving companies with $50 million to $1 billion in revenues or enterprise value. Newly formed Mergers and Acquisitions (M&A) division Newly formed Mergers and Acquisitions (M&A) division, headed by investment banking veterans Jeffrey Sweeney (Chairman and CEO), Charles Towle (COO and Managing Partner), Mitchell R. Cohen (Senior Vice President and Partner), Frank Villarreal (Senior Vice President), and David Reinikanien (Vice President). San Francisco, California, May 05, 2023 (GLOBE NEWSWIRE) — US Capital Global is pleased to announce the launch of its newly formed Mergers and Acquisitions (M&A) division, headed by investment banking veterans Jeffrey Sweeney...

Rapid Micro Biosystems Reports First Quarter 2023 Financial Results

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

Reports first quarter 2023 total revenue of $5.0 million, representing growth of 21%, compared to first quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million, representing growth of approximately 30%, compared to full year 2022 LOWELL, Mass., May 05, 2023 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2023. Recent Highlights First quarter total revenue (combined product and service revenue) increased 21% to $5.0 million First quarter recurring revenue increased 22% to $3.3 million Placed three new systems and...

Ocugen Provides Business Update with First Quarter 2023 Financial Results

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

Conference Call and Webcast Today at 8:30 a.m. ET Announced Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400 for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) Received Orphan Drug Designation (ODD) from the FDA for OCU410ST for the Treatment of ABCA4-Associated Retinopathies Including Stargardt, Retinitis Pigmentosa (RP19), and Cone-Rod Dystrophy 3 (CORD3) Diseases Submitted Multiple Proposals for Federal Funding of Ocugen’s Inhaled Vaccines for COVID-19 and Flu MALVERN, Pa., May 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today reported first quarter 2023 financial results along with a general...

Sprott Announces First Quarter 2023 Results

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

TORONTO, May 05, 2023 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2023. Management commentary “Sprott’s Assets Under Management closed at a record high of $25.4 billion as of March 31, 2023,” said Whitney George, CEO of Sprott. “During the quarter, we benefited from approximately $1 billion in net sales in our private strategies and exchange listed products, as well as strong market value appreciation across the majority of our fund products. Looking ahead, we are confident that our positioning in precious metals and energy transition investments will continue to serve our clients and shareholders well as a global realignment of supply chains and critical mineral production unfolds over the coming years.” Financial...

Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

–Multiple vepdegestrant (ARV-471) studies enrolling globally, including Phase 1, 2, and 3 studies– – Preliminary data from the Phase 1b combination trial of vepdegestrant + palbociclib suggests potential clinical benefit in a heavily pretreated patient population – NEW HAVEN, Conn., May 05, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update. “We made substantial progress throughout the first quarter across all areas of our early- and late-stage pipeline,” said John Houston, Ph.D., president and chief executive officer at Arvinas. “Preliminary data from the ongoing Phase 1b combination study of vepdegestrant with...

Editas Medicine Announces First Quarter 2023 Results and Business Updates

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

Company to provide a clinical update on the EDIT-301 Phase 1/2 RUBY trial for SCD in June at the European Hematology Association Congress (EHA) and in a Company-sponsored webinar On track to dose 20 total patients by year-end in the RUBY trial First patient in EDIT-301 EDITHAL trial for TDT dosed with successful neutrophil and platelet engraftment; Company on track to provide clinical update by year-end Appointed Emma Reeve as Chair of the Board, effective at Annual Meeting of Stockholders, and Elliott Levy, M.D. as an Independent Director CAMBRIDGE, Mass., May 05, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today reported business highlights and financial results for the first quarter 2023. “I am energized by our strong start to the year. We entered 2023 with the objective...

StateHouse Reports Fourth Quarter and Year-End 2022 Financial Results

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

FY 2022 revenue increased 80% to $108.2 million with a 62% improvement in annual gross profit to $42.1 million Expects to achieve positive EBTIDA in 2023 and maintains focus to become cash flow positive before the end of 2023 SAN DIEGO and TORONTO, May 05, 2023 (GLOBE NEWSWIRE) — StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQX: STHZF), a California-focused, vertically integrated cannabis enterprise, today announced its financial results for the three- and twelve-month periods ended December 31, 2022 (“Q4 2022” and “FY 2022”, respectively), and provided additional business updates. The consolidated financial statements for Q4 2022 and FY 2022, as well as the corresponding management’s discussion and analysis are available for download from the Company’s investor website, statehouseholdings.com, and on...

TransUnion Declares First Quarter 2023 Dividend of $0.105 per Share

Written by Customer Service on May 5, 2023. Posted in Dividend Reports And Estimates.

CHICAGO, May 05, 2023 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash dividend of $0.105 per share for the first quarter 2023. The dividend will be payable on June 2, 2023, to shareholders of record on May 19, 2023. About TransUnion (NYSE:TRU) TransUnion is a global information and insights company with over 12,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result,...

Brookfield Business Partners Reports First Quarter 2023 Results

Written by Customer Service on May 5, 2023. Posted in Earnings Releases And Operating Results.

BROOKFIELD, News, May 05, 2023 (GLOBE NEWSWIRE) — Brookfield Business Partners (NYSE: BBUC, BBU; TSX: BBUC, BBU.UN) announced today financial results for the quarter ended March 31, 2023. “We generated solid financial results to start the year supported by the quality of our operations and continued progress on our value creation initiatives,” said Cyrus Madon, CEO of Brookfield Business Partners. “Our focus is on continuing to surface value within our operations and advancing monetization activities, including the sale of Westinghouse, which is on track to close later this year.” Three Months EndedMarch 31, US$ millions (except per unit amounts), unaudited 2023 20225 Net income attributable to unitholders1 $ 74 $ 16 Net income per limited partnership unit2 $ 0.34 $ 0.10 Adjusted EBITDA3 $ 622 $ 486 Net...

Data Fabric Market Size to Surpass USD 9.36 billion by 2030, exhibiting a CAGR of 22.3%

Written by Customer Service on May 5, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global Data Fabric Market Size is projected to reach USD 9.36 billion by 2030, at a CAGR of 22.3% during the forecast period. Pune,India, May 05, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Data Fabric Market Size was valued at USD 1.90 billion in 2022 and is projected to grow from USD 2.29 billion in 2023 to USD 9.36 billion by 2030, exhibiting a CAGR of 22.3% during the forecast period. Growing digitization, rising amounts of data, and concerns regarding data security have boosted the need for data management solutions, thereby driving market expansion in the upcoming years. This information is provided by Fortune Business Insights, in its report titled, Data Fabric Market Forecast, 2023-2030. Key Industry Development- HPE launched HPE Green Lake...

Day: May 5, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice